AdvanceMax Liposomal Melatonin Spray
- The recommended daily dose - 3 puffs
- Natural Mint and natural menthol flavor
- Contains a total of 150 puffs
- Do not precipitate and effervesce
- No need to store in refrigerator
- No need to mix with water or any other drink
- Does not pose a risk of addiction
- Does not contain alcohol, sugar, gluten, lactose
- 1 bottle of 30 ml
- Country of origin: Spain
| Active Ingredient | Quantity (1 puff / 0,2 ml) (3 puff/ 0,6 ml) | %RDA* |
|---|---|---|
Melatonin |
1 mg / 3 mg |
– |
B6 |
0,467 mg / 1,401 mg |
33/100 |
%RDA Recommended Dietary Allowance |
AdvanceMax Liposomal Melatonin Spray
- Liposomal Technology Production
- High Bioavailability
- Each Puff 1 mg Liposomal Melatonin
- 3 Puffs 3 mg Liposomal Melatonin
- Maximum Effect with Lower Dosage Use
- Easy Use
- Directly use to the mouth.
- Suitable swallowing difficulties
- Easy Dosing
- Quality Production and High Stability
- Refreshing Good Taste
About Melatonin and Sleep
The quality of sleep is more important than the length of the sleep. Liposomal Melatonin does not prolong the sleep time. By reducing stress factors, it decreases the time required to fall asleep. It reduces the time to fall asleep by 80% compared to placebo. It provides quality, efficient, uninterrupted, and deeper sleep. It also contributes to quality resting and reduction of fatigue. Thanks to its liposomal structure, it acts all night long. By providing quality sleep, it helps to wake up rested and without drowsiness. It helps to reduce involuntary awakenings at night. It helps regulate and normalize the circadian rhythm. On the other hand, it provides easy use for people with diseases such as Alzheimer’s and dementia, as well as those who have difficulty swallowing. On the other hand, Melatonin is known to reduce the risk of many infections, thanks to its role in regulating the immune system. According to its antioxidant effect, it could also capture or neutralize hydroxyl radicals that occur during aging.
What are the Advantages of Liposomal Melatonin?
- Normal melatonin-containing forms have a bioavailability of around 15-20%.
- AdvanceMax Liposomal Melatonin has 90% and above bioavailability.
- It provides the opportunity to meet the need for high-dose melatonin with the minimum amount of dosage use.
- Bioavailability of 1 mg of Liposomal Melatonin is almost equivalent to 3 mg of normal melatonin.
- Liposomal structure protects against gastro-intestinal side effects.
Produced Using Top Quality Liposomal Technology.
- Manufactured in GMP approved and FDA registered facility.
- It has high Liposomal stability due to high quality production.
- Product has high stability report.
- It is sufficient to store it at room temperature.
- It is not cold chain product.
- It is spray form so that can be applied directly.
- It does not need to be mixed with water or any other beverage.
- Long shelf life – 36 months.
What are the Advantages of Spray Liposomal Melatonin?
- Each puff contains 1mg of Liposomal Melatonin.
- Product contains B6 vitamin to maximize sublingual absorption.
- Dose adjustment – Offers titration.
- Provides use up to 150 puffs.
- In case of need for long-term use, it provides up to 150 days of use.
- Thanks to its natural mint and natural menthol flavor, product has refreshing good taste before sleep
AdvanceMax Liposomal Melatonin Food Supplement 1 Bottle of 30 ml
It is recommended to use 3 puffs per day for adults older than 18 years.
This product should not be used in case of pregnancy, lactation and by people below 18 years old. Do not drive car or work with machines and do not consume alcohol while using this product. This product should not be used more than 2 months. Food supplements should not be used as substitute for normal diet. Do not exceed recommended daily dosage. Keep out of the reach of children. Not for medical use. It is not used for prevention and treatment of diseases. Consult your doctor in case of illness or drug use.
* Turkish Food Codex Nutrition and Health Claims Regulation
*Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: A double-blind, randomised clinical trial, July 2018